Bio-Vin Pharmaceuticals (Hyderabad) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Ebitda
- Net Worth -3.27%
(FY 2022)
- Total Assets 0.01%
(FY 2022)
About Bio-Vin Pharmaceuticals (Hyderabad)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mulamalla Reddy, Jayanthi Katta, and Linga Churukanti serve as directors at the Company.
- CIN/LLPIN
U24110TG2008PTC060815
- Company No.
060815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bio-Vin Pharmaceuticals (Hyderabad)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Linga Churukanti  | Managing Director | 29-Aug-2008 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mulamalla Reddy  | Director | 29-Sep-2022 | Current |
| Jayanthi Katta | Director | 04-Jan-2013 | Current |
Financial Performance and Corporate Structure Insights of Bio-Vin Pharmaceuticals (Hyderabad).
Bio-Vin Pharmaceuticals (Hyderabad) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 3.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bio-Vin Pharmaceuticals (Hyderabad)?
Unlock access to Bio-Vin Pharmaceuticals (Hyderabad)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Anewa Lifesciences Private LimitedActive 8 months 25 daysMulamalla Reddy and Linga Churukanti are mutual person
- Bio-Vin Research Laboratories Private LimitedActive 16 years 10 months
Mulamalla Reddy, Jayanthi Katta and 1 more are mutual person
- Cgs Assets Private LimitedActive 14 years 3 months
Mulamalla Reddy, Jayanthi Katta and 1 more are mutual person
- Quinnharper Pharmaceuticals Private LimitedActive 8 months 19 days
Linga Churukanti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio-Vin Pharmaceuticals (Hyderabad)?
Unlock and access historical data on people associated with Bio-Vin Pharmaceuticals (Hyderabad), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Vin Pharmaceuticals (Hyderabad), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Vin Pharmaceuticals (Hyderabad)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
